An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer’s Disease in Triple-Transgenic Middle-Aged Mice-Reference-Cited by-同舟云学术

An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer’s Disease in Triple-Transgenic Middle-Aged Mice

Published:2022-01-15 Issue:7 Volume:200 Page:3248-3264
ISSN:0163-4984
Container-title:Biological Trace Element Research
language:en
Short-container-title:Biol Trace Elem Res

Author:

He Zhijun,Zheng Lin,Zhao Xu,Li Xiaoqian,Xue Hua,Zhao Qionghui,Ren Bingyu,Li Nan,Ni Jiazuan,Zhang Yan,Liu Qiong

Funder

innovative research group project of the national natural science foundation of china

The Guangdong Provincial Key S&T Program

the Shenzhen Science and Technology Innovation Commission

the Investigation and evaluation of neural mechanisms associated with development of language, emotion, and cognitive disorders

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12011-021-02938-1.pdf

Reference72 articles.

1. Murphy MP (2018) Amyloid-beta solubility in the treatment of Alzheimer’s disease. N Engl J Med 378(4):391–392. https://doi.org/10.1056/NEJMe1714638

2. Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M et al (2018) Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 378(4):321–330. https://doi.org/10.1056/NEJMoa1705971

3. Jin N, Zhu H, Liang X, Huang W, Xie Q, Xiao P et al (2017) Sodium selenate activated Wnt/beta-catenin signaling and repressed amyloid-beta formation in a triple transgenic mouse model of Alzheimer’s disease. Exp Neurol 297:36–49. https://doi.org/10.1016/j.expneurol.2017.07.006

4. Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases. Nat Cell Biol 6(11):1054–1061. https://doi.org/10.1038/ncb1104-1054

5. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82(12):4245–4249. https://doi.org/10.1073/pnas.82.12.4245

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer perspectives of vanadium complexes;Inorganic Chemistry Communications;2024-03

2. Vanadium complexes: potential candidates for therapeutic applications;Transition Metal Chemistry;2023-12-13

3. The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD;Current Issues in Molecular Biology;2023-07-31

4. The Design of Metal Complexes to Target the Amyloid‐β Peptide in Alzheimer's Disease;Encyclopedia of Inorganic and Bioinorganic Chemistry;2023-06-27